When an RSV vaccine became available for use during pregnancy, it offered a natural experiment between various countries to ...

Respiratory Syncytial Virus (RSV) poses a significant threat to Indian infants, particularly during post-monsoon and winter, ...

RSV leads to over 100,000 infant deaths annually, but WHO’s latest guidance recommends maternal vaccines and monoclonal ...

Experts say new immunisation program working, but some babies missing outThe number of Australian babies admitted to hospital ...

Adults hospitalized for RSV face higher odds of cardiac complications than those with COVID-19 or influenza, especially in ...

Wastewater monitoring helps communities spot rising outbreaks of influenza, COVID, RSV, and more. Our writer gets her feet ...

Discover a study that highlights the importance of identifying high-risk children through biomarkers and better understanding ...

“I had actually only heard of RSV in passing conversation. I hadn't actually looked after anyone with RSV,” she explained.

Many babies are heading into winter without full protection against the leading cause of severe respiratory illness in ...

On June 2, 2025, Southeast Asia and India marked a historic milestone in the fight against respiratory syncytial virus (RSV), ...

A single injection of nirsevimab, a long-acting monoclonal antibody developed to prevent respiratory syncytial virus (RSV) ...

RSV seasons ended earlier than usual in 2022-23 and 2023-24, and typical human hMPV circulation patterns have returned since the COVID-19 pandemic.